Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal ...

Abbott, a global healthcare leader, announced the US commercial launch of SimpleScreen CRC, an FDA-approved blood-based colorectal cancer (CRC) screening test for adults age 45 and older who are at ...

The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based ...

Adding a blood test to routine screening found about 6.5 times as many cancers in adults over 50, including many at an early stage.

Abbott will sell Freenome’s SimpleScreen CRC test in the U.S. alongside the Cologuard Plus stool-based test it gained in the $21 billion acquisition of Exact Sciences.

According to the former Fierce 15 winner, the test’s sensitivity was able to deliver a negative predictive value of 99.7%, or a 3-in-1,000 chance of lung cancer with a negative result. (Cecilia ...

Share on Pinterest A new screening test could help diagnose lung cancer earlier than traditional CT scans. Andriy Onufriyenko/Getty Images About 1.8 million deaths each year are attributable to lung ...